SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-24-047467
Filing Date
2024-05-29
Accepted
2024-05-29 16:15:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0207008-424b5_enlivex.htm 424B5 314286
2 GRAPHIC image_001.jpg GRAPHIC 2500
3 GRAPHIC image_002.jpg GRAPHIC 23408
  Complete submission text file 0001213900-24-047467.txt   351506
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264561 | Film No.: 24998616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)